A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

A study published in The British Journal of Psychiatry has revealed new insights into the connection between joint ...

AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.